Is vitamin D status relevant to metabolic syndrome?

References

• Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626 - 32; http://dx.doi.org/10.1001/archinternmed.2008.604; PMID: 19307527
   PubMed Web of Science ®Google Scholar
• Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’?. Br J Nutr 1998; 79:315 - 27; http://dx.doi.org/10.1079/BJN19980055; PMID: 9624222
   PubMed Web of Science ®Google Scholar
• Chowdhury TA, Boucher BJ, Hitman GA. Vitamin D and type 2 diabetes: Is there a link?. Prim Care Diabetes 2009; 3:115 - 6; http://dx.doi.org/10.1016/j.pcd.2009.03.004; PMID: 19395331
   PubMedGoogle Scholar
• DeLuca HF. Historical overview of vitamin D. In Vitamin D.3rd ed. Ed Feldman D, Wesley Pike J, Adams JS. 2011 Vol 1; Chap 1, pp3-12. Academic Press, Elsevier. London etc.
   Google Scholar
• Adams JS, Chen H, Chun R, Ren S, Wu S, Gacad M, et al. Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J Bone Miner Res 2007; 22:Suppl 2 V20 - 4; http://dx.doi.org/10.1359/jbmr.07s214; PMID: 18290716
   PubMedGoogle Scholar
• Jablonski NG, Chaplin G. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc Natl Acad Sci U S A 2010; 107:Suppl 2 8962 - 8; http://dx.doi.org/10.1073/pnas.0914628107; PMID: 20445093
   PubMed Web of Science ®Google Scholar
• Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72:690 - 3; PMID: 10966885
   PubMed Web of Science ®Google Scholar
• Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012; In press http://dx.doi.org/10.1038/oby.2011.404; PMID: 22262154
   PubMed Web of Science ®Google Scholar
• DiGiorgi M, Daud A, Inabnet WB, Schrope B, Urban-Skuro M, Restuccia N, et al. Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg 2008; 18:1144 - 8; http://dx.doi.org/10.1007/s11695-007-9408-4; PMID: 18335295
   PubMed Web of Science ®Google Scholar
• Soares MJ, Ping-Delfos WC, Sherriff JL, Nezhad DH, Cummings NK, Zhao Y. Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect?. Eur J Clin Nutr 2011; 65:1348 - 52; http://dx.doi.org/10.1038/ejcn.2011.111; PMID: 21712836
   PubMed Web of Science ®Google Scholar
• Prentice A. Vitamin D deficiency: a global perspective. [review] Nutr Rev 2008; 66:Suppl 2 S153 - 64; http://dx.doi.org/10.1111/j.1753-4887.2008.00100.x; PMID: 18844843
   PubMed Web of Science ®Google Scholar
• Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011; 96:E447 - 52; http://dx.doi.org/10.1210/jc.2010-2230; PMID: 21177785
   PubMed Web of Science ®Google Scholar
• Berry D, Hyppönen E. Determinants of vitamin D status: focus on genetic variations. Curr Opin Nephrol Hypertens 2011; 20:331 - 6; http://dx.doi.org/10.1097/MNH.0b013e328346d6ba; PMID: 21654390
   PubMed Web of Science ®Google Scholar
• Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002; 51:2294 - 300; http://dx.doi.org/10.2337/diabetes.51.7.2294; PMID: 12086963
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20:1352 - 60; http://dx.doi.org/10.1101/gr.107920.110; PMID: 20736230
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266 - 81; http://dx.doi.org/10.1056/NEJMra070553; PMID: 17634462
   PubMed Web of Science ®Google Scholar
• Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, et al, Alcohol Genome-wide Association (AlcGen) Consortium, Diabetes Genetics Replication and Meta-analyses (DIAGRAM+) Study, Genetic Investigation of Anthropometric Traits (GIANT) Consortium, Global Lipids Genetics Consortium, Genetics of Liver Disease (GOLD) Consortium, International Consortium for Blood Pressure (ICBP-GWAS), Meta-analyses of Glucose and Insulin-Related Traits Consortium (MAGIC). Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011; 43:1131 - 8; http://dx.doi.org/10.1038/ng.970; PMID: 22001757
   PubMed Web of Science ®Google Scholar
• Kujala UM, Jokelainen J, Oksa H, Saaristo T, Rautio N, Moilanen L, et al. Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes. BMJ Open 2011; 1:e000292; http://dx.doi.org/10.1136/bmjopen-2011-000292; PMID: 22184585
   PubMedGoogle Scholar
• Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?. Curr Pharm Des 2010; 16:3939 - 847; PMID: 21128892
   PubMedGoogle Scholar
• Towers TL, Freedman LP. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J Biol Chem 1998; 273:10338 - 48; http://dx.doi.org/10.1074/jbc.273.17.10338; PMID: 9553089
   PubMed Web of Science ®Google Scholar
• Boucher BJ. Vitamin D insufficiency and diabetes risks. [Review] Curr Drug Targets 2011; 12:61 - 87; http://dx.doi.org/10.2174/138945011793591653; PMID: 20795936
   PubMed Web of Science ®Google Scholar
• Schrijver J, van den Berg H. [Nutrition and health--vitamins and vitamin supplements]. Ned Tijdschr Geneeskd 2003; 147:752 - 6; PMID: 12731465
   PubMedGoogle Scholar
• Butte NF, Fox MK, Briefel RR, Siega-Riz AM, Dwyer JT, Deming DM, et al. Nutrient intakes of US infants, toddlers, and preschoolers meet or exceed dietary reference intakes. J Am Diet Assoc 2010; 110:Suppl S27 - 37; http://dx.doi.org/10.1016/j.jada.2010.09.004; PMID: 21092766
   PubMedGoogle Scholar
• Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79:820 - 5; PMID: 15113720
   PubMed Web of Science ®Google Scholar
• Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997; 40:344 - 7; http://dx.doi.org/10.1007/s001250050685; PMID: 9084975
   PubMed Web of Science ®Google Scholar
• Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28:1228 - 30; http://dx.doi.org/10.2337/diacare.28.5.1228; PMID: 15855599
   PubMed Web of Science ®Google Scholar
• Hyppönen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57:298 - 305; http://dx.doi.org/10.2337/db07-1122; PMID: 18003755
   PubMed Web of Science ®Google Scholar
• Boucher BJ. Inverse correlation between serum free IGF-1 and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes by Capoluongo et al. Cytokine 2007; 37:181 - 2 author reply 183-4. Epub 2007 Mar 26. Comment on Cytokine. 2006; 34:303-11
   PubMed Web of Science ®Google Scholar
• Ford ES, Zhao G, Li C, Pearson WS. Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States. J Diabetes 2009; 1:296 - 303; http://dx.doi.org/10.1111/j.1753-0407.2009.00046.x; PMID: 20923530
   PubMedGoogle Scholar
• Brenner DR, Arora P, Garcia-Bailo B, Wolever TMS, Morrison H, El-Sohemy A, et al. Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clin Invest Med 2011; 34:E377 - 84; PMID: 22129928
   PubMedGoogle Scholar
• Lee DM, Rutter MK, O’Neill TW, Boonen S, Vanderschueren D, Bouillon R, et al, European Male Ageing Study Group. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009; 161:947 - 54; http://dx.doi.org/10.1530/EJE-09-0496; PMID: 19773367
   PubMed Web of Science ®Google Scholar
• Oosterwerff MM, Eekhoff EM, Heymans MW, Lips P, van Schoor NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clin Endocrinol (Oxf) 2011; 75:608 - 13; http://dx.doi.org/10.1111/j.1365-2265.2011.04110.x; PMID: 21595731
   PubMed Web of Science ®Google Scholar
• Richart T, Thijs L, Nawrot T, Yu JM, Kuznetsova T, Balkestein EJ, et al. The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population. Am J Hypertens 2011; 24:102 - 9; http://dx.doi.org/10.1038/ajh.2010.124; PMID: 20596035
   PubMed Web of Science ®Google Scholar
• Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 1992; 12:671 - 4; http://dx.doi.org/10.1161/01.ATV.12.6.671; PMID: 1350464
   PubMedGoogle Scholar
• John WG, Noonan K, Mannan N, Boucher BJ. Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. Am J Clin Nutr 2005; 82:517 - 22; PMID: 16155262
   PubMed Web of Science ®Google Scholar
• Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010; 171:903 - 8; http://dx.doi.org/10.1093/aje/kwq005; PMID: 20219763
   PubMed Web of Science ®Google Scholar
• Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 2010; 64:1457 - 64; http://dx.doi.org/10.1038/ejcn.2010.176; PMID: 20823896
   PubMed Web of Science ®Google Scholar
• Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32:1278 - 83; http://dx.doi.org/10.2337/dc09-0209; PMID: 19366976
   PubMed Web of Science ®Google Scholar
• Kim MK, Il Kang M, Won Oh K, Kwon HS, Lee JH, Lee WC, et al. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 2010; 73:330 - 8; http://dx.doi.org/10.1111/j.1365-2265.2010.03798.x; PMID: 20184597
   PubMed Web of Science ®Google Scholar
• Devaraj S, Jialal G, Cook T, Siegel D, Jialal I. Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm Metab Res 2011; 43:72 - 4; http://dx.doi.org/10.1055/s-0030-1268485; PMID: 21110290
   PubMed Web of Science ®Google Scholar
• Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011; 60:1475 - 81; http://dx.doi.org/10.1016/j.metabol.2011.03.002; PMID: 21550088
   PubMed Web of Science ®Google Scholar
• Ngo DT, Chan WP, Rajendran S, Heresztyn T, Amarasekera A, Sverdlov AL, et al. Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 2011; 25:326 - 30; http://dx.doi.org/10.1016/j.niox.2011.06.005; PMID: 21741493
   PubMed Web of Science ®Google Scholar
• Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011; 165:603 - 11; http://dx.doi.org/10.1530/EJE-11-0545; PMID: 21753070
   PubMed Web of Science ®Google Scholar
• Muldowney S, Lucey AJ, Paschos G, Martinez JA, Bandarra N, Thorsdottir I, et al. Relationships between vitamin D status and cardio-metabolic risk factors in young European adults. Ann Nutr Metab 2011; 58:85 - 93; http://dx.doi.org/10.1159/000324600; PMID: 21474925
   PubMed Web of Science ®Google Scholar
• Bonakdaran S, Varasteh AR. Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med J 2009; 30:509 - 14; PMID: 19370277
   PubMed Web of Science ®Google Scholar
• McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7:4; http://dx.doi.org/10.1186/1475-2891-7-4; PMID: 18226257
   PubMed Web of Science ®Google Scholar
• Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26:573 - 80; http://dx.doi.org/10.1016/j.clnu.2007.05.009; PMID: 17624643
   PubMed Web of Science ®Google Scholar
• Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 2011; 9:85; http://dx.doi.org/10.1186/1741-7015-9-85; PMID: 21749681
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17:517 - 24; http://dx.doi.org/10.1016/j.numecd.2006.04.002; PMID: 16928437
   PubMed Web of Science ®Google Scholar
• Zúñiga S, Firrincieli D, Housset C, Chignard N. Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 2011; 35:295 - 302; http://dx.doi.org/10.1016/j.clinre.2011.02.003; PMID: 21440524
   PubMed Web of Science ®Google Scholar
• Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011; 60:1728 - 37; http://dx.doi.org/10.1136/gut.2010.234666; PMID: 21816960
   PubMed Web of Science ®Google Scholar
• Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr 2011; 94:225 - 33; http://dx.doi.org/10.3945/ajcn.111.013516; PMID: 21613551
   PubMed Web of Science ®Google Scholar
• Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 2010; 33:1373 - 5; http://dx.doi.org/10.2337/dc09-2199; PMID: 20332348
   PubMed Web of Science ®Google Scholar
• Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009; 3:289 - 96; http://dx.doi.org/10.1016/j.jacl.2009.07.003; PMID: 21291826
   PubMed Web of Science ®Google Scholar
• Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC, et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 2011; 96:168 - 75; http://dx.doi.org/10.1210/jc.2010-1439; PMID: 20980431
   PubMed Web of Science ®Google Scholar
• Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, Martin LW, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94:209 - 17; http://dx.doi.org/10.3945/ajcn.110.010272; PMID: 21613558
   PubMed Web of Science ®Google Scholar
• Reis JP, von Mühlen D, Miller ER 3rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009; 124:e371 - 9; http://dx.doi.org/10.1542/peds.2009-0213; PMID: 19661053
   PubMed Web of Science ®Google Scholar
• Ashraf AP, Alvarez JA, Gower BA, Saenz KH, McCormick KL. Associations of serum 25-hyrdoxyvitamin D and components of the metabolic syndrome in obese adolescent females. Obesity (Silver Spring) 2011,
   Google Scholar
• Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, Booth SL, et al. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 2010; 91:1627 - 33; http://dx.doi.org/10.3945/ajcn.2009.28441; PMID: 20392893
   PubMed Web of Science ®Google Scholar
• Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al, Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106:963 - 8; http://dx.doi.org/10.1016/j.amjcard.2010.05.027; PMID: 20854958
   PubMed Web of Science ®Google Scholar
• Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139:329 - 34; http://dx.doi.org/10.3945/jn.108.093831; PMID: 19106328
   PubMed Web of Science ®Google Scholar
• Brock KE, Huang WY, Fraser DR, Ke L, Tseng M, Mason RS, et al. Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihyrdorxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung. Colorectal and Ovarian Cancer Screening Trial 2011; 106:339 - 44
   Google Scholar
• Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009; 8:7; http://dx.doi.org/10.1186/1475-2840-8-7; PMID: 19187564
   PubMed Web of Science ®Google Scholar
• Saltevo J, Niskanen L, Kautiainen H, Teittinen J, Oksa H, Korpi-Hyövälti E, et al. Serum calcium level is associated with metabolic syndrome in the general population: FIN-D2D study. Eur J Endocrinol 2011; 165:429 - 34; http://dx.doi.org/10.1530/EJE-11-0066; PMID: 21659455
   PubMed Web of Science ®Google Scholar
• Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 1997; 46:1171 - 7; http://dx.doi.org/10.1016/S0026-0495(97)90212-2; PMID: 9322802
   PubMed Web of Science ®Google Scholar
• Kim MK, Kim G, Jang EH, Kwon HS, Baek KH, Oh KW, et al. Altered calcium homeostasis is correlated with the presence of metabolic syndrome and diabetes in middle-aged and elderly Korean subjects: the Chungju Metabolic Disease Cohort study (CMC study). Atherosclerosis 2010; 212:674 - 81; http://dx.doi.org/10.1016/j.atherosclerosis.2010.07.005; PMID: 20728085
   PubMed Web of Science ®Google Scholar
• Majumdar V, Nagaraja D, Christopher R. Vitamin D status and metabolic syndrome in Asian Indians. Int J Obes (Lond) 2011; 35:1131 - 4; http://dx.doi.org/10.1038/ijo.2010.232; PMID: 21060309
   PubMed Web of Science ®Google Scholar
• Forouhi NG, Luan JJ, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008; 57:2619 - 25; http://dx.doi.org/10.2337/db08-0593; PMID: 18591391
   PubMed Web of Science ®Google Scholar
• Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007; 30:1549 - 55; http://dx.doi.org/10.2337/dc06-2438; PMID: 17351276
   PubMed Web of Science ®Google Scholar
• Rueda S, Ferńndez-Ferńndez C, Romero F, Martínez de Osaba J, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008; 18:151 - 4; http://dx.doi.org/10.1007/s11695-007-9352-3; PMID: 18175193
   PubMed Web of Science ®Google Scholar
• Gulseth HL, Gjelstad IM, Tierney AC, Lovegrove JA, Defoort C, Blaak EE, et al. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 2010; 33:923 - 5; http://dx.doi.org/10.2337/dc09-1692; PMID: 20067973
   PubMed Web of Science ®Google Scholar
• Del Gobbo LC, Song Y, Dannenbaum DA, Dewailly E, Egeland GM. Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. J Nutr 2011; 141:290 - 5; http://dx.doi.org/10.3945/jn.110.129619; PMID: 21178079
   PubMed Web of Science ®Google Scholar
• Knekt P, Laaksonen M, Mattila C, Härkänen T, Marniemi J, Heliövaara M, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008; 19:666 - 71; http://dx.doi.org/10.1097/EDE.0b013e318176b8ad; PMID: 18496468
   PubMed Web of Science ®Google Scholar
• Laaksonen MA, Knekt P, Rissanen H, Härkänen T, Virtala E, Marniemi J, et al. The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. Eur J Epidemiol 2010; 25:115 - 24; http://dx.doi.org/10.1007/s10654-009-9405-0; PMID: 20012885
   PubMed Web of Science ®Google Scholar
• Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011; 34:1133 - 8; http://dx.doi.org/10.2337/dc10-2167; PMID: 21430082
   PubMed Web of Science ®Google Scholar
• Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 2010; 27:1107 - 15; http://dx.doi.org/10.1111/j.1464-5491.2010.03092.x; PMID: 20854377
   PubMed Web of Science ®Google Scholar
• Zhang C, Qiu C, Hu FH, David RM, van Damn RM, Bralley A, et al. Maternal plasma 25-hydroxyvitamin D concentration and the risk for gestational diabetes. PLoS 2008; 3:33753
   Google Scholar
• Makgoba M, Nelson SM, Savvidou M, Messow CM, Nicolaides K, Sattar N. First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus. Diabetes Care 2011; 34:1091 - 3; http://dx.doi.org/10.2337/dc10-2264; PMID: 21454797
   PubMed Web of Science ®Google Scholar
• Avenell A, Cook JA, MacLennan GS. McPherson GC for the RECORD trial group for etc; Vitamin D supplementation and type 2 diabetes: a sub-study of a randomized placebo-controlled trial in older people. http://ageing.oxford
   Google Scholar
• de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, et al, Women’s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women’s Health Initiative. Diabetes Care 2008; 31:701 - 7; http://dx.doi.org/10.2337/dc07-1829; PMID: 18235052
   PubMed Web of Science ®Google Scholar
• Tai K, Need AG, Horowitz M, Chapman IM. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008; 24:950 - 6; http://dx.doi.org/10.1016/j.nut.2008.04.009; PMID: 18653316
   PubMed Web of Science ®Google Scholar
• Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 2011; 60:2947 - 53; http://dx.doi.org/10.2337/db11-0465; PMID: 21911752
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Al-Othman A, et al. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. [Epub ahead of print] Metabolism 2011; http://dx.doi.org/10.1016/j.metabol.2011.09.017; PMID: 22075268
   PubMed Web of Science ®Google Scholar
• Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hasanzadeh J. Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr 2011; 20:521 - 6; PMID: 22094836
   PubMed Web of Science ®Google Scholar
• Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. QJM 2002; 95:787 - 96; http://dx.doi.org/10.1093/qjmed/95.12.787; PMID: 12454321
   PubMed Web of Science ®Google Scholar
• Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94:486 - 94; http://dx.doi.org/10.3945/ajcn.111.011684; PMID: 21715514
   PubMed Web of Science ®Google Scholar
• Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract 2010; 16:600 - 8; http://dx.doi.org/10.4158/EP09300.OR; PMID: 20350923
   PubMed Web of Science ®Google Scholar
• Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Kalayi A, et al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev 2012; In press http://dx.doi.org/10.1002/dmrr.2290; PMID: 22344966
   PubMed Web of Science ®Google Scholar
• Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 2012; 30:284 - 9; http://dx.doi.org/10.1097/HJH.0b013e32834e1f0a; PMID: 22179077
   PubMed Web of Science ®Google Scholar
• Khalili H, Talasaz AH, Salarifar M. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. [Epub ahead of print] Clin Res Cardiol 2011; http://dx.doi.org/10.1007/s00392-011-0394-0; PMID: 22159952
   PubMed Web of Science ®Google Scholar
• Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012; 109:359 - 63; http://dx.doi.org/10.1016/j.amjcard.2011.09.020; PMID: 22071212
   PubMed Web of Science ®Google Scholar
• Gotsman I, Schauer A, Zwas DR, Hellman Y, Keren A, Lotan C, Admon D. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure: vitamin D supplementation improves outcome. Eur J Herat Fail 2012; In press
   Google Scholar
• Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol 2010; 162:935 - 42; http://dx.doi.org/10.1530/EJE-09-1041; PMID: 20185562
   PubMed Web of Science ®Google Scholar
• Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96:1931 - 42; http://dx.doi.org/10.1210/jc.2011-0398; PMID: 21677037
   PubMed Web of Science ®Google Scholar
• Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95:91 - 100; http://dx.doi.org/10.3945/ajcn.111.014779; PMID: 22170374
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011; 6:CD007470; PMID: 21735411
   PubMedGoogle Scholar
• Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010; 65:225 - 36; http://dx.doi.org/10.1016/j.maturitas.2009.12.013; PMID: 20031348
   PubMed Web of Science ®Google Scholar
• Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011; 75:575 - 84; http://dx.doi.org/10.1111/j.1365-2265.2011.04147.x; PMID: 21682758
   PubMed Web of Science ®Google Scholar
• Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2011; In press PMID: 22071212
   PubMed Web of Science ®Google Scholar
• Petchey WG, Hickman IJ, Duncan E, Prins JB, Hawley CM, Johnson DW, et al. The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial. BMC Nephrol 2009; 10:41; http://dx.doi.org/10.1186/1471-2369-10-41; PMID: 20003316
   PubMed Web of Science ®Google Scholar
• Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30:980 - 6; http://dx.doi.org/10.2337/dc06-1994; PMID: 17277040
   PubMed Web of Science ®Google Scholar
• Guillot X, Semerano L, Saidenberg-Kermanac’h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010; 77:552 - 7; http://dx.doi.org/10.1016/j.jbspin.2010.09.018; PMID: 21067953
   PubMed Web of Science ®Google Scholar
• Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011; 65:1016 - 26; http://dx.doi.org/10.1038/ejcn.2011.68; PMID: 21731036
   PubMed Web of Science ®Google Scholar
• Milner RD, Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 1967; 3:47 - 9; http://dx.doi.org/10.1007/BF01269910; PMID: 4903553
   PubMedGoogle Scholar
• Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92:2017 - 29; http://dx.doi.org/10.1210/jc.2007-0298; PMID: 17389701
   PubMed Web of Science ®Google Scholar
• Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 2010; 33:2021 - 3; http://dx.doi.org/10.2337/dc10-0790; PMID: 20805275
   PubMed Web of Science ®Google Scholar
• Mozaffari-Khosravi H, Hosseinzadeh-Shamsi-Anar MA, Salami M-A, Hadinedoushan H, Mozayan MR. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus. Diabet Med 2012; 29:36 - 42; http://dx.doi.org/10.1111/j.1464-5491.2011.03473.x; PMID: 21977923
   PubMed Web of Science ®Google Scholar
• Boucher BJ. Calcium supplements may increase the risk of cardiovascular events in postmenopausal women. Evid Based Med 2012; 17:16 - 7; http://dx.doi.org/10.1136/ebm.2011.100113; PMID: 22028370
   PubMedGoogle Scholar
• Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995; 38:1239 - 45; http://dx.doi.org/10.1007/BF00422375; PMID: 8690178
   PubMed Web of Science ®Google Scholar
• Luo C, Wong J, Brown M, Hooper M, Molyneaux L, Yue DK. Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diab Vasc Dis Res 2009; 6:194 - 9; http://dx.doi.org/10.1177/1479164109337974; PMID: 20368211
   PubMed Web of Science ®Google Scholar
• Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26:19 - 27; http://dx.doi.org/10.1111/j.1464-5491.2008.02636.x; PMID: 19125756
   PubMed Web of Science ®Google Scholar
• von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient—a randomised, placebo-controlled trial. Br J Nutr 2010; 103:549 - 55; http://dx.doi.org/10.1017/S0007114509992017; PMID: 19781131
   PubMed Web of Science ®Google Scholar
• Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial. J Diabetes 2010; 2:36 - 40; http://dx.doi.org/10.1111/j.1753-0407.2009.00057.x; PMID: 20923473
   PubMed Web of Science ®Google Scholar
• Jain R, von Hurst PR, Stonehouse W, Love DR, Higgins CM, Coad J. Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. Metabolism 2012; In press http://dx.doi.org/10.1016/j.metabol.2011.06.018; PMID: 21871642
   PubMed Web of Science ®Google Scholar
• Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002; 51:356 - 9; http://dx.doi.org/10.1053/meta.2002.29969; PMID: 11887173
   PubMed Web of Science ®Google Scholar
• Filus A, Trzmiel A, Kuliczkowska-Płaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 2008; 11:134 - 9; http://dx.doi.org/10.1080/13685530802273426; PMID: 18821289
   PubMed Web of Science ®Google Scholar
• Tworowska-Bardzińska U, Lwow F, Kubicka E, Łaczmański Ł, Jedzrzejuk D, Dunajska K, et al. The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecol Endocrinol 2008; 24:514 - 8; http://dx.doi.org/10.1080/09513590802302985; PMID: 18958772
   PubMed Web of Science ®Google Scholar
• Davidson HW, Rhodes CJ, Hutton JC. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature 1988; 333:93 - 6; http://dx.doi.org/10.1038/333093a0; PMID: 3283564
   PubMed Web of Science ®Google Scholar
• Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229 - 38; PMID: 12122115
   PubMed Web of Science ®Google Scholar
• de Kloet AD, Krause EG, Woods SC. The renin angiotensin system and the metabolic syndrome. Physiol Behav 2010; 100:525 - 34; http://dx.doi.org/10.1016/j.physbeh.2010.03.018; PMID: 20381510
   PubMed Web of Science ®Google Scholar
• Cheng Q, Li YC, Boucher BJ, Leung PS. A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia 2011; 54:2077 - 81; http://dx.doi.org/10.1007/s00125-011-2100-1; PMID: 21424540
   PubMed Web of Science ®Google Scholar
• Chan SP, Scott BB, Sen SS. An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: physician and patient attitudes and beliefs. BMC Musculoskelet Disord 2010; 11:248; PMID: 20977729
   PubMed Web of Science ®Google Scholar
• Awumey EM, Mitra DA, Hollis BW, Kumar R, Bell NH. Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endocrinol Metab 1998; 83:169 - 73; http://dx.doi.org/10.1210/jc.83.1.169; PMID: 9435436
   PubMed Web of Science ®Google Scholar
• Boucher BJ, Mannan N. Metabolic effects of the consumption of Areca catechu. Addict Biol 2002; 7:103 - 10; http://dx.doi.org/10.1080/13556210120091464; PMID: 11900629
   PubMed Web of Science ®Google Scholar
• Boucher BJ, Ewen SWB, Stowers JM. Betel nut (Areca catechu) consumption and the induction of glucose intolerance in adult CD1 mice and in their F1 and F2 offspring. Diabetologia 1994; 37:49 - 55; http://dx.doi.org/10.1007/BF00428777; PMID: 8150230
   PubMed Web of Science ®Google Scholar
• Mannan N, Boucher BJ, Evans SJ. Increased waist size and weight in relation to consumption of Areca catechu (betel-nut); a risk factor for increased glycaemia in Asians in east London. Br J Nutr 2000; 83:267 - 75; PMID: 10884715
   PubMed Web of Science ®Google Scholar
• Chen TH-H, Chiu Y-H, Boucher BJ. Transgenerational effects of betel-quid chewing on the development of the metabolic syndrome in the Keelung Community-based Integrated Screening Program. Am J Clin Nutr 2006; 83:688 - 92; PMID: 16522918
   PubMed Web of Science ®Google Scholar
• Yen AM, Chiu YH, Chen LS, Wu HM, Huang CC, Boucher BJ, et al. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 2006; 83:1153 - 60; PMID: 16685060
   PubMed Web of Science ®Google Scholar
• Ogunkolade WB, Boucher BJ, Bustin SA, Burrin JM, Noonan K, Mannan N, et al. Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing “betel nut” (Areca catechu) and vitamin D status. J Clin Endocrinol Metab 2006; 91:2612 - 7; http://dx.doi.org/10.1210/jc.2005-2750; PMID: 16670168
   PubMed Web of Science ®Google Scholar
• Wagner D, Hanwell HE, Schnabl K, Yazdanpanah M, Kimball S, Fu L, et al. The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation. J Steroid Biochem Mol Biol 2011; 126:72 - 7; http://dx.doi.org/10.1016/j.jsbmb.2011.05.003; PMID: 21605672
   PubMed Web of Science ®Google Scholar
• Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes?. [Erratum in Diabetologia 2005; 48:1677] Diabetologia 2005; 48:1038 - 50; http://dx.doi.org/10.1007/s00125-005-1764-9; PMID: 15864529
   PubMed Web of Science ®Google Scholar
• Thorand B, Zierer A, Huth C, Linseisen J, Meisinger C, Roden M, et al. Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study. Diabetes Care 2011; 34:2320 - 2; http://dx.doi.org/10.2337/dc11-0775; PMID: 21873558
   PubMed Web of Science ®Google Scholar
• Riachy R, Vandewalle B, Moerman E, Belaich S, Lukowiak B, Gmyr V, et al. 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 2006; 11:151 - 9; http://dx.doi.org/10.1007/s10495-006-3558-z; PMID: 16502254
   PubMed Web of Science ®Google Scholar
• Riachy R, Vandewalle B, Belaich S, Kerr-Conte J, Gmyr V, Zerimech F, et al. Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. J Endocrinol 2001; 169:161 - 8; http://dx.doi.org/10.1677/joe.0.1690161; PMID: 11250657
   PubMed Web of Science ®Google Scholar
• Garcia-Bailo B, El-Sohemy A, Haddad PS, Arora P, Benzaied F, Karmali M, et al. Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. Biologics 2011; 5:7 - 19; PMID: 21383912
   PubMedGoogle Scholar
• Arora P, Garcia-Bailo B, Dastani Z, Brenner D, Viteligas A, Malik S, et al. Genetic pathways of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. MC Med Genet 2011; 14:12 - 95
   Google Scholar
• Fu LW, Vender R. Review. Systemic role for vitamin D in the treatment of psoriasis and metabolic syndrome. Derm Res Persp 2011; 2011: ID 276079.
   Google Scholar
• Bock G, Prietl B, Mader JK, Höller E, Wolf M, Pilz S, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev 2011; 27:942 - 5; http://dx.doi.org/10.1002/dmrr.1276; PMID: 22069289
   PubMed Web of Science ®Google Scholar
• Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011; 106:Suppl 3 S5 - 78; http://dx.doi.org/10.1017/S0007114511005460; PMID: 22133051
   PubMed Web of Science ®Google Scholar
• McMillan A, Hicks J, Isabella C, Higa GM. A critical analysis of the (near) legendary status of vitamin D. Expert Rev Endocrinol Metab 2012; 7:103 - 19; http://dx.doi.org/10.1586/eem.11.81
   PubMedGoogle Scholar
• Grant WB, Boucher BJ. Requirements for Vitamin D across the life span. Biol Res Nurs 2011; 13:120 - 33; http://dx.doi.org/10.1177/1099800410391243; PMID: 21242196
   PubMed Web of Science ®Google Scholar
• Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121:297 - 300; http://dx.doi.org/10.1016/j.jsbmb.2010.02.021; PMID: 20197091
   PubMed Web of Science ®Google Scholar
• Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecological meta-regression analysis. Osteoporosis 2009; 20:133 - 40; http://dx.doi.org/10.1007/s00198-008-0626-y
   PubMed Web of Science ®Google Scholar
• Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53 - 8; http://dx.doi.org/10.1210/jc.2010-2704; PMID: 21118827
   PubMed Web of Science ®Google Scholar
• Whitton C, Nicholson SK, Roberts C, Prynne CJ, Pot GK, Olson A, et al. National Diet and Nutrition Survey: UK food consumption and nutrient intakes from the first year of the rolling programme and comparisons with previous surveys. Br J Nutr 2011; 106:1899 - 914; http://dx.doi.org/10.1017/S0007114511002340; PMID: 21736781
   PubMed Web of Science ®Google Scholar
• Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007; 85:649 - 50; PMID: 17344484
   PubMed Web of Science ®Google Scholar
• Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9:709 - 15; http://dx.doi.org/10.1016/j.autrev.2010.06.009; PMID: 20601202
   PubMed Web of Science ®Google Scholar
• Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 1999; 53:920 - 6; http://dx.doi.org/10.1038/sj.ejcn.1600870; PMID: 10602348
   PubMed Web of Science ®Google Scholar
• Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011; 31:607 - 11; PMID: 21378345
   PubMed Web of Science ®Google Scholar
• Heald A, Stephens R, Gibson JM. The insulin-like growth factor system and diabetes--an overview. [Review] Diabet Med 2006; 23:Suppl 1 19 - 24; http://dx.doi.org/10.1111/j.1464-5491.2006.01833f.x; PMID: 16483261
   PubMedGoogle Scholar
• Park Y, Kim M. Serum 25-hydroxyvitamin D concentrations are associated with erythrocyte levels of n-3 PUFA but not risk of CVD. Br J Nutr 2011; 106:1529 - 34; http://dx.doi.org/10.1017/S0007114511001930; PMID: 21736802
   PubMed Web of Science ®Google Scholar
• Grant WB. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 2011; 3:199 - 204; PMID: 22110780
   PubMedGoogle Scholar
• Newman MS, Brandon TR, Groves MN, Gregory WL, Kapur S, Zava DT. A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening. J Diabetes Sci Technol 2009; 3:156 - 62; PMID: 20046660
   PubMedGoogle Scholar
• O’Sullivan A, Gibney MJ, Connor AO, Mion B, Kaluskar S, Cashman KD, et al. Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res 2011; 55:679 - 90; http://dx.doi.org/10.1002/mnfr.201000458; PMID: 21240901
   PubMed Web of Science ®Google Scholar
• Cashman KD, Fitzgerald AP, Kiely M, Seamans KM. A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations. Br J Nutr 2011; 106:1638 - 48; http://dx.doi.org/10.1017/S0007114511005058; PMID: 22000709
   PubMed Web of Science ®Google Scholar
• Cashman KD, Kiely M. Towards prevention of vitamin D deficiency and beyond: knowledge gaps and research needs in vitamin D nutrition and public health. Br J Nutr 2011; 106:1617 - 27; http://dx.doi.org/10.1017/S0007114511004995; PMID: 22017772
   PubMed Web of Science ®Google Scholar
• Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, et al, Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006; 367:36 - 43; http://dx.doi.org/10.1016/S0140-6736(06)67922-1; PMID: 16399151
   PubMed Web of Science ®Google Scholar
• Sayers A, Tilling K, Boucher BJ, Noonan K, Tobias JH. Predicting ambient ultraviolet from routine meteorological data; its potential use as an instrumental variable for vitamin D status in pregnancy in a longitudinal birth cohort in the UK. Int J Epidemiol 2009; 38:1681 - 8; http://dx.doi.org/10.1093/ije/dyp237; PMID: 19564248
   PubMed Web of Science ®Google Scholar
• Lanham-New SA, Buttriss JL, Miles LM, Ashwell M, Berry JL, Boucher BJ, et al. Proceedings of the Rank Forum on Vitamin D. Br J Nutr 2011; 105:144 - 56; http://dx.doi.org/10.1017/S0007114510002576; PMID: 21134331
   PubMedGoogle Scholar
• Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011; 26:455 - 7; http://dx.doi.org/10.1002/jbmr.328; PMID: 21337617
   PubMed Web of Science ®Google Scholar
• Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011; 9:48; http://dx.doi.org/10.1186/1741-7015-9-48; PMID: 21542944
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911 - 30; http://dx.doi.org/10.1210/jc.2011-0385; PMID: 21646368
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, et al. EMAS position statement: Vitamin D and postmenopausal health. Maturitas 2012; 71:83 - 8; http://dx.doi.org/10.1016/j.maturitas.2011.11.002; PMID: 22100145
   PubMed Web of Science ®Google Scholar
• Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 2012; 30:284 - 9; http://dx.doi.org/10.1097/HJH.0b013e32834e1f0a; PMID: 22179077
   PubMed Web of Science ®Google Scholar